MongoDB enters its June 30 earnings window with a sharp contradiction at its core: the stock fell 15% on the week to $340.28, yet the analyst community is raising price targets and borrowing conditions show no meaningful short pressure.
The earnings context matters here. The last print — delivered May 29 — triggered a 24% single-day rally, with a further 8% over the following week. Before that, the prior result produced a 14% gain with a 29% five-day follow-through. That's a streak of genuinely large positive reactions, which makes the current pullback a notable setup into the June 30 event. Notably, B of A Securities raised its target to $450 just two days ago — one of the most recent and consequential analyst moves in the dataset — following a prior raise to $390 immediately after the May earnings beat. That double step-up from a bellwether firm in two weeks tells a clear story about how the buy side is reading the momentum.
The broader analyst picture is constructive but not uniformly bullish. Targets clustered higher following the May results, with multiple firms lifting to the $390–$455 range. The two neutrals in the mix — UBS raised to $350 and Macquarie to $315 — are now sitting below the current price at $340, which means their implied views are modestly negative on a risk-adjusted basis while the bulls are pointing to $450 and above. The consensus mean of $397 represents about 17% upside from current levels. Valuation remains stretched: the PE multiple is around 51x and EV/EBITDA near 37x, though both have compressed over the past week alongside the price drop. Forward EPS momentum is strong, ranking in the 93rd percentile for 12-month forward year-on-year increase — the bull case rests almost entirely on continued Atlas growth and MongoDB's positioning as a backend for AI workloads.
The positioning picture is genuinely untroubled. Short interest is at 4.5% of the free float — meaningful but not aggressive — and actually fell 4% on the week, the opposite of what you'd expect if bears were pressing the pullback. Borrow availability is extraordinarily loose, with over 5,000% of shares-short still available to borrow, compared to a 52-week low of roughly 2,400%. Cost to borrow sits near 0.5%, up about 10% on the week but still firmly in the low-cost bracket — far from any squeeze dynamic. Options positioning adds a similar read: the put/call ratio of 0.63 is slightly below its 20-day average of 0.69, meaning options traders are not reaching for downside protection despite the stock's rough week. This is a week where shorts covered and options stayed calm through a 15% drawdown — not the profile of a market bracing for more pain.
Insider activity is worth noting, though interpretation is limited without broader context. CEO Dev Ittycheria sold approximately $15m worth of shares on June 4, across multiple tranches at prices ranging from $381 to $387. That follows a period of strong stock performance and came just ahead of the week's selloff. At the same time, co-founder Dwight Merriman appears in the top holders list with a 30,000-share reduction in his position as of mid-May. Net 90-day insider activity is actually slightly positive in share terms at +100,000 shares, though the recent sales suggest senior holders were lightening up near the highs.
Among close peers, the week's selling was broad: SNOW fell 8%, OKTA dropped 11%, and TWLO lost 11% — meaning MDB's 15% decline outpaced the peer group but wasn't dramatically out of step with a sector-wide de-rating. The ORTEX short score has ticked down slightly to 35.8, reinforcing that the data reads as moderate rather than elevated short pressure.
With earnings due June 30 and a two-print streak of double-digit positive reactions, the tension to watch is whether the selloff represents a reset of expectations ahead of the print, or whether the AI-backend narrative that powered those prior moves is showing early signs of fatigue.
See the live data behind this article on ORTEX.
Open MDB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
